Akamai CEO, Twilio CEO & Homework: MindMedicine
The Dow fell 94 points today and Jim Cramer’s highlighting some leaders in market. Then, Cramer‘s joined by Akamai’s CEO talking the rise of cyber attacks in the U.S. and how the 20 year old company plans to defend against them. Then, Twilio’s CEO discusses how they’re helping out in the vaccine front and how the business looks going forward. Plus, Cramer’s turning in his homework on MindMedicine, the company studying psychedelic drugs used as treatment for serious afflictions.
June 15, 202144m 48s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The Dow fell 94 points today and Jim Cramer’s highlighting some leaders in market. Then, Cramer‘s joined by Akamai’s CEO talking the rise of cyber attacks in the U.S. and how the 20 year old company plans to defend against them. Then, Twilio’s CEO discusses how they’re helping out in the vaccine front and how the business looks going forward. Plus, Cramer’s turning in his homework on MindMedicine, the company studying psychedelic drugs used as treatment for serious afflictions. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.